Securities code: 688202 securities abbreviation: Shanghai Medicilon Inc(688202) Announcement No.: 2022-004 Shanghai Medicilon Inc(688202)
Suggestive announcement on the disclosure of the plan for issuing A-Shares to specific objects
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
Shanghai Medicilon Inc(688202) (hereinafter referred to as “the company”) held the second meeting of the third board of directors and the second meeting of the third board of supervisors on February 10, 2022. The meeting deliberated and adopted relevant proposals on the company’s issuance of A-Shares to specific objects in 2022. Relevant documents such as the plan for issuing A-Shares to specific objects in Shanghai Medicilon Inc(688202) 2022 and the demonstration and analysis report on the plan for issuing A-Shares to specific objects in Shanghai Medicilon Inc(688202) 2022 have been posted on the website of Shanghai Stock Exchange（ http://www.sse.com.cn. ）Disclosure, please pay attention to the majority of investors.
The disclosure of the company’s plan to issue A-Shares to specific objects in 2022 does not represent the substantive judgment, confirmation or approval of the audit and registration departments on matters related to this issuance, The effectiveness and completion of the matters related to this issuance described in the plan for issuing A-Shares to specific objects have yet to be considered by the general meeting of shareholders of the company and reviewed by Shanghai Stock Exchange, and registered with China Securities Regulatory Commission.
Please pay attention to investment risks.
It is hereby announced.
Shanghai Medicilon Inc(688202) board of directors February 11, 2022
